141 related articles for article (PubMed ID: 10411119)
21. Expression, localization, and thyrotropin regulation of cathepsin D in human thyroid tissues.
Métayé T; Kraimps JL; Goujon JM; Fernandez B; Quellard N; Ingrand P; Barbier J; Bégon F
J Clin Endocrinol Metab; 1997 Oct; 82(10):3383-8. PubMed ID: 9329373
[TBL] [Abstract][Full Text] [Related]
22. Thyroglobulin suppresses thyroid-specific gene expression in cultures of normal but not neoplastic human thyroid follicular cells.
Ishido Y; Yamazaki K; Kammori M; Sugishita Y; Luo Y; Yamada E; Yamada T; Sellitti DF; Suzuki K
J Clin Endocrinol Metab; 2014 Apr; 99(4):E694-702. PubMed ID: 24433000
[TBL] [Abstract][Full Text] [Related]
23. Expression of transforming growth factor beta1, beta2, and beta3 in multinodular goiters and differentiated thyroid carcinomas: a comparative study.
Kimura ET; Kopp P; Zbaeren J; Asmis LM; Ruchti C; Maciel RM; Studer H
Thyroid; 1999 Feb; 9(2):119-25. PubMed ID: 10090310
[TBL] [Abstract][Full Text] [Related]
24. Nuclear localization of epidermal growth factor and epidermal growth factor receptors in human thyroid tissues.
Marti U; Ruchti C; Kämpf J; Thomas GA; Williams ED; Peter HJ; Gerber H; Bürgi U
Thyroid; 2001 Feb; 11(2):137-45. PubMed ID: 11288982
[TBL] [Abstract][Full Text] [Related]
25. Identification of apoptotic proteins in thyroid gland from patients with Graves' disease and Hashimoto's thyroiditis.
Bossowski A; Czarnocka B; Bardadin K; Stasiak-Barmuta A; Urban M; Dadan J; Ratomski K; Bossowska A
Autoimmunity; 2008 Mar; 41(2):163-73. PubMed ID: 18324486
[TBL] [Abstract][Full Text] [Related]
26. Proteomic analysis of thyroid tissue reveals enhanced catabolic activity in Graves' disease compared to toxic multinodular goitre.
Temiz Karadag D; Cetinarslan B; Kasap M; Canturk NZ; Akpinar G; Canturk Z; Tarkun I; Simsek T; Selek A
Cell Biochem Funct; 2021 Jul; 39(5):658-666. PubMed ID: 33728674
[TBL] [Abstract][Full Text] [Related]
27. Study on cathepsin B activity in human thyroid tumors.
Kusunoki T; Nishida S; Nakano T; Funasaka K; Kimoto S; Murata K; Tomura T
Auris Nasus Larynx; 1995; 22(1):43-8. PubMed ID: 7677635
[TBL] [Abstract][Full Text] [Related]
28. Aberrant deoxyribonucleic acid methylation in human thyroid tumors.
Matsuo K; Tang SH; Zeki K; Gutman RA; Fagin JA
J Clin Endocrinol Metab; 1993 Oct; 77(4):991-5. PubMed ID: 7691865
[TBL] [Abstract][Full Text] [Related]
29. p27kip1 expression distinguishes papillary hyperplasia in Graves' disease from papillary thyroid carcinoma.
Erickson LA; Yousef OM; Jin L; Lohse CM; Pankratz VS; Lloyd RV
Mod Pathol; 2000 Sep; 13(9):1014-9. PubMed ID: 11007042
[TBL] [Abstract][Full Text] [Related]
30. Increased lipid peroxidation and impaired enzymatic antioxidant defense mechanism in thyroid tissue with multinodular goiter and papillary carcinoma.
Erdamar H; Cimen B; Gülcemal H; Saraymen R; Yerer B; Demirci H
Clin Biochem; 2010 May; 43(7-8):650-4. PubMed ID: 20171198
[TBL] [Abstract][Full Text] [Related]
31. [Thyroid diseases in sub-Saharan Africa].
Sidibé el H
Sante; 2007; 17(1):33-9. PubMed ID: 17897900
[TBL] [Abstract][Full Text] [Related]
32. Somatostatin receptor 2 expression determined by immunohistochemistry in cold thyroid nodules exceeds that of hot thyroid nodules, papillary thyroid carcinoma, and Graves' disease.
Sancak S; Hardt A; Singer J; Klöppel G; Eren FT; Güllüoglu BM; Sen LS; Sever Z; Akalin NS; Eszlinger M; Paschke R
Thyroid; 2010 May; 20(5):505-11. PubMed ID: 20450431
[TBL] [Abstract][Full Text] [Related]
33. Evaluation and management of multinodular goiter.
Hurley DL; Gharib H
Otolaryngol Clin North Am; 1996 Aug; 29(4):527-40. PubMed ID: 8844728
[TBL] [Abstract][Full Text] [Related]
34. Fibroblast growth factors 1 and 2 and fibroblast growth factor receptor 1 are elevated in thyroid hyperplasia.
Thompson SD; Franklyn JA; Watkinson JC; Verhaeg JM; Sheppard MC; Eggo MC
J Clin Endocrinol Metab; 1998 Apr; 83(4):1336-41. PubMed ID: 9543164
[TBL] [Abstract][Full Text] [Related]
35. Dysregulation of clathrin promotes thyroid cell growth and contributes to multinodular goiter pathogenesis.
Lau ST; Zhou T; Liu JA; Fung EY; Che CM; Lang BH; Ngan ES
Biochim Biophys Acta; 2015 Aug; 1852(8):1676-86. PubMed ID: 25981745
[TBL] [Abstract][Full Text] [Related]
36. [Hyperthyroidism and carcinoma of the thyroid gland].
Ardito G; Mantovani M; Vincenzoni C; Guidi ML; Corsello S; Rabitti C; Fadda G; Di Giovanni V
Ann Ital Chir; 1997; 68(1):23-7; discussion 27-8. PubMed ID: 9235859
[TBL] [Abstract][Full Text] [Related]
37. Characterization of ligands for galectins, natural galactoside-binding immunoglobulin G subfractions and sarcolectin and also of the expression of calcyclin in thyroid lesions.
Nagy N; Decaestecker C; Dong X; Kaltner H; Schüring MP; Rocmans P; Danguy A; Gabius HJ; Kiss R; Salmon I
Histol Histopathol; 2000 Apr; 15(2):503-13. PubMed ID: 10809372
[TBL] [Abstract][Full Text] [Related]
38. Immunohistochemical studies on thyroid peroxidase and thyroglobulin in 13 human thyroid tumors and 7 Graves' goiters.
Watanabe K; Koizumi N; Ozaki O; Futaesaku Y; Hosoya T
Endocr J; 1993 Dec; 40(6):683-90. PubMed ID: 7951537
[TBL] [Abstract][Full Text] [Related]
39. High expression of cathepsin B in transitional bladder carcinoma correlates with tumor invasion.
Eiján AM; Sandes EO; Riveros MD; Thompson S; Pasik L; Mallagrino H; Celeste F; Casabé AR
Cancer; 2003 Jul; 98(2):262-8. PubMed ID: 12872343
[TBL] [Abstract][Full Text] [Related]
40. Expression of the Na+/I- symporter gene in human thyroid tumors: a comparison study with other thyroid-specific genes.
Lazar V; Bidart JM; Caillou B; Mahé C; Lacroix L; Filetti S; Schlumberger M
J Clin Endocrinol Metab; 1999 Sep; 84(9):3228-34. PubMed ID: 10487692
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
